Metraipolis › archive › dc_242e702c053d

Mechanistic modeling suggests stroma-targeting antibody-drug conjugates as an alternative to cancer-targeting in cases of heterogeneous target exspression — Europe PMC PMID:40802833

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40802833
DOI
10.1371/journal.pcbi.1012839
License (as archived)
solo-consultazione
Archived
2026-10-08T08:27:24.809Z
SHA-256 of the archived text
01ef935684aafec465e2fb6794cbc392965e2c28badfd1f24560ff7a44c2db85
Stable URL of this page
https://metraipolis.com/documento/dc_242e702c053d

How to cite

Mechanistic modeling suggests stroma-targeting antibody-drug conjugates as an alternative to cancer-targeting in cases of heterogeneous target exspression — Europe PMC PMID:40802833 — Europe PMC (en), https://europepmc.org/article/MED/40802833 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_242e702c053d (Metraipolis archive dc_242e702c053d, sha256 01ef935684aafec465e2fb6794cbc392965e2c28badfd1f24560ff7a44c2db85)
BibTeX
@misc{dc242e702c053d,
  title = {Mechanistic modeling suggests stroma-targeting antibody-drug conjugates as an alternative to cancer-targeting in cases of heterogeneous target exspression — Europe PMC PMID:40802833},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40802833},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_242e702c053d; sha256 01ef935684aafec465e2fb6794cbc392965e2c28badfd1f24560ff7a44c2db85},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40802833. Agents can read the archived copy with the MCP tool read_document.